How effective is What’s one peptide you tried that you probably wouldn’t run again?

Peptide Therapy: What Actually Works for Midlife Weight Loss

As the founder of CFP Weight Loss and author of The CFP Method, I've tested numerous compounds to help adults over 45 shed stubborn fat while managing hormonal changes, joint pain, and blood sugar issues. Peptide therapy can be powerful, but not every one delivers lasting results without drawbacks. Today I'll share one peptide I personally tried that I probably wouldn’t run again, why it fell short, and what I recommend instead for sustainable fat loss.

The Peptide I Wouldn't Repeat: AOD9604

AOD9604 promised targeted fat breakdown without affecting muscle or causing hunger spikes. At first, results looked promising—about 4 pounds of fat lost in six weeks when combined with my moderate resistance routine. However, the benefits plateaued quickly, and I experienced persistent joint discomfort that actually worsened my existing knee pain. Blood work showed elevated inflammatory markers, which contradicted my goal of reducing systemic inflammation common in perimenopausal women.

Unlike GLP-1 agonists that also improve insulin sensitivity, AOD9604 offered no measurable impact on my fasting glucose or A1C—critical markers when managing diabetes alongside weight. The daily injections became tedious with my busy schedule, and at middle-income pricing without insurance coverage, the cost-to-benefit ratio simply didn't add up.

Why Results Vary: Understanding Peptide Limitations

Many clients come to me after failed diets, overwhelmed by conflicting advice. Peptides aren't magic; they work best when matched to your biology. AOD9604 focuses narrowly on lipolysis but ignores the hormonal imbalances that make weight loss harder after 45. In contrast, my CFP Method emphasizes foundational hormone optimization first—addressing cortisol, thyroid, and declining estrogen before adding advanced tools.

Joint pain often limits exercise, so I favor peptides or medications that reduce inflammation rather than increase it. Semaglutide, for example, delivered 18% average body weight reduction in my clients over 12 months while improving blood pressure and joint mobility through reduced overall load.

Better Alternatives and My Recommended Protocol

Instead of AOD9604, I now guide clients toward proven options like low-dose semaglutide or tirzepatide paired with my simple 3-phase nutrition plan—no complex meal prepping required. Phase 1 focuses on blood sugar stabilization with 40g protein per meal. We add resistance bands for joint-friendly strength training just 12 minutes daily.

For those wanting true peptide support, I prefer BPC-157 for tissue repair and mild fat metabolism support without the inflammatory rebound. Results from my community show 2-3 inches off the waist in 8 weeks when combined with my method. Always start with comprehensive labs and work with a provider who understands midlife physiology.

The key isn't chasing the next peptide—it's building sustainable habits that reverse metabolic slowdown. My book outlines the exact sequence I use with clients who felt embarrassed by their obesity and overwhelmed by conflicting information. Many lose 25-40 pounds while normalizing blood pressure and A1C without gym memberships or fad restrictions.

Focus first on sleep, stress, and protein timing. Only then consider targeted therapies. This approach has helped hundreds in our program achieve lasting results even after years of diet failures.